This review highlights the importance of monitoring critically ill patients in the ICU for drug-induced cardiovascular adverse events, including arrhythmias, blood pressure abnormalities, and heart failure.
Alerts clinicians to drug-induced CV risks in ICU; leaves open need for prospective monitoring protocols.
Critically ill patients are at high risk of adverse drug events during their intensive care unit stay. Of the potential adverse drug events, those related to the cardiovascular system are particularly concerning. Common cardiovascular adverse drug events include drug-induced arrhythmias, drug-induced blood pressure abnormalities, and drug-induced heart failure. The specific drug-induced events to be reviewed include bradycardia, tachycardia, corrected QT interval prolongation, hypertension, hypotension, and heart failure exacerbation.
No takes yet. Share an insight, caveat, or question.
Kennelly et al. (2013) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: